Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link in place of study information.
    Difference
    0.5%
    Check dated 2026-10-03T13:50:44.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, with a basic HTML header/footer and a 403 title, replacing the previous study content for the NCT03783078 study.
    Difference
    19%
    Check dated 2026-09-19T21:53:10.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Added 2018 U.S. NIH Grant/Contract funding attribution. Updated the page revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:21.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page has been updated to Revision: v3.6.5 and the Plain Language Summary has been removed; the prior Revision: v3.6.4 note has also been removed, altering how trial details are displayed to users.
    Difference
    0.1%
    Check dated 2026-08-08T23:09:57.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.6.4 label appears on the page, replacing the previous Revision: v3.6.3, indicating a recent CMS or content update. This update does not change the study data, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-07-25T12:56:50.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page now displays a new revision label, v3.6.3, replacing the previous v3.6.2, indicating a minor maintenance update to the entry.
    Difference
    0.0%
    Check dated 2026-07-03T23:20:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.